St. Jude Medical announced the first U.S. implant in the company’s LEADLESS II pivotal trial designed to evaluate the Nanostim leadless pacemaker for U.S. Food and Drug Administration approval. The world’s first retrievable, non-surgical pacemaker was implanted at The Mount Sinai Hospital in New York City. The company said, "This clinical research trial will be testing the latest innovative, non-surgical pacemaker option for U.S. patients experiencing heart rhythm issues. This pioneering, compact device, which is placed directly inside the heart, may be a true game-changing technology in cardiovascular medicine and may help revolutionize care for patients with arrhythmias."
- Health Care Industry
- St. Jude Medical